Skip to main content
SpringerLink
Log in

Calcium antagonists and endothelial function: Focus on nitric oxide and endothelin

  • Pharmacology: New Aspects of Calcium Antagonists
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

This paper reports on some interactions of calcium antagonists with nitric oxide and endothelin. It reviews evidence showing that the vasorelaxant action of calcium antagonists is facilitated by nitric oxide and describes the mechanism of this modulation. The interaction of calcium antagonists with endothelin is examined considering functions and production of the peptide. Among the functions examined, attention is drawn to the potentiation of responses to vasoconstrictors evoked by low threshold concentrations of endothelin, an action that could be important in pathology. The production of endothelin is increased by a high-salt diet in spontaneous hypertensive stroke-prone rats, this increased production, related to the overexpression of prepro ET-1mRNA, is responsible for cardiovascular hypertrophy and is blunted, in a blood pressure-unrelated manner, by the calcium antagonist lacidipine. At the same dosage regimen, lacidipine inhibits the hypertrophy of the cardiovascular system evoked by a high-salt diet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Godfraind T, Kaba A. Blockade or reversal of contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol 1969;36:549–560.

    Google Scholar 

  2. Godfraind T, Miller RC, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986;38:321–416.

    Google Scholar 

  3. Fleckenstein A, ed. Calcium Antagonism in Heart and Smooth Muscle. Experimental Facts and Therapeutic Prospects. New York: John Wiley, 1983.

    Google Scholar 

  4. Godfraind T. Calcium antagonists and vasodilatation. Pharmacol Ther 1994;64:37–75.

    Google Scholar 

  5. Moncada S, Plamer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109–142.

    Google Scholar 

  6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411–415.

    Google Scholar 

  7. Glossmann H, Lübbecke F, Mewes R, Derry DR, Hosmann F. Calcium channels: Direct identification with radioligand binding studies. Trends Pharmacol Sci 1982;3:431–437.

    Google Scholar 

  8. Spedding M. Calcium antagonist subgroups. Trends Pharmacol Sci 1985;6:109–114.

    Google Scholar 

  9. Tsien RW, Ellinor PT, Horne WA. Molecular diversity of voltage-dependent Ca2+ channels. Trends Pharmacol Sci 1989;10:349–354.

    Google Scholar 

  10. Varadi G, Mori Y, Mikala G, Schwartz A. Molecular determinants of Ca2+ channel function and drug action. Trends Pharmacol Sci 1995;16:43–49.

    Google Scholar 

  11. Spedding M, Paoletti R. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 1992;44:363–376.

    Google Scholar 

  12. Hosey MM, Lazdunski M. Calcium channels: Molecular pharmacology, structure and regulation. J Memb Biol 1988;104:81–105.

    Google Scholar 

  13. McKenna E, Koch WJ, Slish DF, Schwartz A. Toward an understanding of the dihydropyridine-sensitive calcium channel. Biochem Pharmacol 1990;39:1145–1150.

    Google Scholar 

  14. Feron O, Octave J-N, Christen M-O, Godfraind T. Quantification of two splicing events in the L-type calcium channel 446–1 subunit of intestinal smooth muscle and other tissues. Eur J Biochem 1994;222:195–202.

    Google Scholar 

  15. Salomone S, Silva LM, Morel N, Godfraind T. Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery. Naunyn Schmiedebergs Arch Pharmacol 1996, in press.

  16. Salomone S, Morel N, Godfraind T. Effects of 8-bromocyclic GMP and verapamil on depolarization-evoked Ca2+ signal and contraction in rat aorta. Br J Pharmacol 1995;114:1731–1737.

    Google Scholar 

  17. Boulanger CM, Nakashima M, Olmos L, Joly G, Vanhoutte PM. Effects of the Ca2+ antagonist Ro 40–5967 on endothelium-dependent responses of isolated arteries. J Cardiovasc Pharmacol 1994;23:869–876.

    Google Scholar 

  18. Szabo C, Thiemermann C, Vane J. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun 1993;196:825–830.

    Google Scholar 

  19. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 1989;10:374–378.

    Google Scholar 

  20. Balligand JL, Godfraind T. Effect of nisoldipine on the contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins. J Cardiovasc Pharmacol 1994;24:618–625.

    Google Scholar 

  21. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 1993;110:1201–1205.

    Google Scholar 

  22. Hartter E, Woloszczuk W. Radioimmunoassay of endothelin. Lancet 1989;1:909.

    Google Scholar 

  23. Davenport AP, Ashby MJ, Easton P, et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990;78:261–264.

    Google Scholar 

  24. Luscher TF. Endothelin: Key to coronary vasospasm? Circulation 1990;83:701–703.

    Google Scholar 

  25. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of introcoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991;324:648–654.

    Google Scholar 

  26. Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation in isolated canine coronary arteries. J Clin Invest 1986;78:539–544.

    Google Scholar 

  27. Schiffrin EL. Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension 1995;25:1135–1143.

    Google Scholar 

  28. Kurihara Y, Kurihara H, Suzuki H, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703–710.

    Google Scholar 

  29. Hoffman A, Grossman E, Abassi ZA, Keiser HR. Renal endothelin and hypertension. Nature 1994;372:50.

    Google Scholar 

  30. Suzuki T, Hoshi H, Mitsui Y. Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS Lett 1990;268:149–151.

    Google Scholar 

  31. Ito H, Hirata H, Hiroe M, et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991;69:209–215.

    Google Scholar 

  32. Campese VM. Salt sensitivity in hypertension: Renal and cardiovascular implications. Hypertension 1994;23:531–550.

    Google Scholar 

  33. Beil AH, Schmieder RE, Messerli FH. Salt intake, blood pressure and cardiovascular structure. Cardiovasc Drugs Ther 1994;8:425–432.

    Google Scholar 

  34. Feron O, Salomone S, Godfraind T. Inhibition by lacidipine of salt-dependent cardiac hypertrophy and endothelin gene expression in stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun 1995;210:219–224.

    Google Scholar 

  35. Battistini B, Chailler P, D'Orléans-Juste P, Brière N, Sirois P. Growth regulatory properties of endothelins. Peptides 1993;14:385–399.

    Google Scholar 

  36. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294–300.

    Google Scholar 

  37. Ito H, Hirata Y, Adachi S, et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92: 398–403.

    Google Scholar 

  38. Sung C-P, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther 1994; 271: 429–437.

    Google Scholar 

  39. Volpe M, Camargo MJF, Mueller FB, et al. Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. Hypertension 1990: 15: 318–326.

    Google Scholar 

  40. Yamashita Y, Takata Y, Takishita S, Kimura Y, Fujishima M. Enhancement of brain renin-angiotensin system induced by long-term salt loading in spontaneously hypertensive rats. J Hypertens 1986; 4: S361-S363.

    Google Scholar 

  41. Feron O, Salomone S, Godfraind T. Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats. Br J Pharmacol 1996; 118: 659–664.

    Google Scholar 

  42. Grohe C, Nouskas J, Vetter H, Neyses L. Effects of nisoldipine on endothelin-1- and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. J Cardiovasc Pharmacol 1994; 24: 13–16.

    Google Scholar 

  43. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plama endothelin-1 in acute ischemic stroke. Stroke 1992; 23: 1014–1016.

    Google Scholar 

  44. Stanimirovic DB, Bertrand N, McCarron R, Uematsu S, Spatz M. Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium. Acta Neurochir Suppl Wien 1994; 60: 71–75.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Pharmacologie, Université Catholique de Louvain, Avenue Hippocrate, Brussels, Belgium

    Théophile Godfraind & Salvatore Salomone

Authors
  1. Théophile Godfraind
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Salomone
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Godfraind, T., Salomone, S. Calcium antagonists and endothelial function: Focus on nitric oxide and endothelin. Cardiovasc Drug Ther 10, 439–446 (1996). https://doi.org/10.1007/BF00051108

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00051108

Key Words

Search

Navigation